Search company, investor...


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$1.25M | 11 yrs ago

About Provasculon

Provasculon was founded to exploit the discovery by Richard Lee, MD, a cardiologist at Brigham and Women's Hospital and Associate Professor at Harvard Medical School, and Vincent Segers, MD, a researcher at Brigham and Women's Hospital, of forms of the growth factor Stromal Cell-Derived Factor-1 (SDF-1).

Headquarters Location

14 Cambridge Center

Cambridge, Massachusetts, 02142,

United States


Missing: Provasculon's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Provasculon's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Provasculon Frequently Asked Questions (FAQ)

  • When was Provasculon founded?

    Provasculon was founded in 2007.

  • Where is Provasculon's headquarters?

    Provasculon's headquarters is located at 14 Cambridge Center, Cambridge.

  • What is Provasculon's latest funding round?

    Provasculon's latest funding round is Unattributed VC.

  • How much did Provasculon raise?

    Provasculon raised a total of $6M.

  • Who are the investors of Provasculon?

    Investors of Provasculon include Broadview Ventures, Biogen Idec New Ventures, Partners Innovation Fund and Partnersnnovation Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.